"Designing Growth Strategies is in our DNA"

Intravenous (IV) Iron Drugs Market Size, Share and Global Trend By Type (Iron Sucrose, Dextran, Ferric Carboxyl Maltose, Ferric Gluconate), By Application (Gynecology, Oncology, Nephrology), By End User (Hospitals, Ambulatory Surgery Centers, Homecare Settings) and Geography Forecast till 2030

Region : Global | Report ID: FBI101236 | Status : Ongoing



Iron is part of hemoglobin, and carries the oxygen in the blood and also enables the production of red blood cells. When an individual is deficient in iron requirements of the body, the diagnosed condition is known as anemia. Some of the symptoms of anemia include loss of energy and fatigue, unusually rapid heartbeat while exercising, difficulty in concentration, pale skin and dizziness, insomnia and cramps. According to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017, approximetly 30% women and children in developing countries suffering from anemia.

According to the American Society of Hematology, anemia is the most common blood disorder in the U.S. and affects more than 3 million individuals in the U.S. Increasing prevalence of anemia, increasing prevalence of associated diseases leading to anemia are some of the factors propelling the growth of the global intravenous (IV) iron drugs market.

To gain extensive insights into the market, Request for Customization

Additionally, increasing research and development in intravenous iron, rising demand for preventive medical care, and expanding treatment options for anemia are some of the factors boosting the global intravenous (IV) iron drugs market growth.

The factors limiting the growth of the global intravenous (IV) iron drugs market are the associated side effects of the intravenous (IV) iron drugs and specific safety issues associated with the procedure. This combined with lack of adherence to treatment among patient population especially in emerging countries, are major factors restraining the growth of the global market.

Key Players Covered

The major companies covered in the global intravenous (IV) iron drugs market report Daiichi Sankyo, Inc., Sanofi, AMAG Pharmaceuticals, Inc., Allergan, Nippon Shinyaku Co., Lt, and Pharmacosmos A/S., and others.




By Type

· Iron Sucrose

· Dextran

· Ferric Carboxyl Maltose

· Ferric Gluconate

· Others

By Application

· Gynecology

· Oncology

· Nephrology

· Others

By End User

· Hospitals

· Ambulatory Surgery Centers

· Homecare Settings

· Others

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


As per the current intravenous (IV) iron drugs market trends, increased use and intake of IV iron drugs among chronic kidney disease patients has led to the nephrology segment accounting for largest market share.

Key Insights

  • Pipeline Analysis

  • Recent Advancements in Global Intravenous (IV) Iron Drugs Market

  • Key mergers and acquisitions

Regional Analysis

The global intravenous (IV) iron drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the intravenous (IV) iron drugs market in 2018 due to a number of factors such as the increasing prevalence of anemia, increasing incidence for associated diseases such as celiac disease and inflammatory bowel disease, high healthcare expenditure, access to advanced intravenous (IV) iron drugs due to advancements in research & development and rising demand for preventive medical care. Asia Pacific is projected to be the fastest emerging market due to increasing awareness and incidence of anemia, increasing access to intravenous (IV) iron drugs, rising prevalence of acute and severe diseases such as inflammatory bowel disease. Latin America and the Middle East and Africa are anticipated to grow at a relatively lower CAGR during the forecast period.

Intravenous (IV) Iron Drugs Industry Developments

  • In May 2019, Rockwell Medical, Inc., submitted new Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the Intravenous (I.V.) formulation of Triferic
  • In April 2018, AMAG Pharmaceuticals received FDA approval for supplemental new drug application for ferumoxytol injection to include all eligible adults with iron-deficiency anemia (IDA) who cannot tolerate or have not responded to oral iron.

  • Ongoing
  • 2022
  • 2019-2021


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.